TERMS AND CONDITIONS FOR MOBERG PHARMA AB (PUBL)
MAXIMUM SEK 600,000,000 SENIOR UNSECURED CALLABLE FLOATING RATE
BONDS 2016/2021 ISIN: SE0007953989
Issue Date: 29 January 2016
The distribution o f this document and the private placement o f the Bonds in certainjurisdictions may be restricted by law. Persons into whose possession this document comes are required to
inform themselves about, and to observe, such restrictions. The Bonds have not been and will not be registered under the U.S. Securities Act o f 1933, as amended, and are subject to U.S. tax law requirements. The Bonds may not be offered, sold or delivered within the United States o fAmerica or to, orfor the account or benefit of, U.S. persons.
TABLE OF CONTENTS
1. DEFINITIONS AND CONSTRUCTION................................................................................1 2. THE AMOUNT OF THE BONDS AND UNDERTAKING TO MAKE PAYMENTS........ 12 3. STATUS OF THE BONDS..................................................................................................12 4. USE OF PROCEEDS......................................................................................................... 13 5. THE BONDS AND TRANSFERABILITY...........................................................................13 6. BONDS IN BOOK-ENTRY FORM..................................................................................... 13 7. RIGHT TO ACT ON BEHALF OF A HOLDER.................................................................. 14 8. PAYMENTS IN RESPECT OF THE BONDS.................................................................... 14 9. INTEREST........................................................................................................................... 15 10. REDEMPTION AND REPURCHASE OF THE BONDS................................................... 16 11. SPECIAL UNDERTAKINGS...............................................................................................17 12. TERMINATION OF THE BONDS......................................................................................20 13. DISTRIBUTION OF PROCEEDS.....................................................................................23 14. DECISIONS BY HOLDERS............................................................................................... 24 15. HOLDERS' MEETING........................................................................................................ 27 16. WRITTEN PROCEDURE................................................................................................... 28 17. AMENDMENTS AND WAIVERS..................................................................................... 28 18. APPOINTMENT AND REPLACEMENT OF THE AGENT............................................. 29 19. APPOINTMENT AND REPLACEMENT OF THE ISSUING AGENT.............................. 33 20. APPOINTMENT AND REPLACEMENT OF THE CSD....................................................33 21. NO DIRECT ACTIONS BY HOLDERS............................................................................ 33 22. TIME-BAR............................................................................................................................ 34 23. NOTICES AND PRESS RELEASES................................................................................. 34 24. FORCE MAJEURE AND LIMITATION OF LIABILITY......................................................35 25. LISTING............................................................................................................................... 35 26. GOVERNING LAW AND JURISDICTION.........................................................................36
TERMS AND CONDITIONS FOR MOBERG PHARMA AB (PUBL)
